{"id":"NCT01297517","sponsor":"Alcon Research","briefTitle":"Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%","officialTitle":"Three Month Efficacy and Safety Study of a Fixed Combination of Brinzolamide 1%/Brimonidine 0.2% Compared to Brinzolamide 1% and Brimonidine 0.2% All Dosed Three Times Daily in Patients With Open-Angle Glaucoma and/or Ocular Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-02","primaryCompletion":"2012-03","completion":"2012-03","firstPosted":"2011-02-16","resultsPosted":"2013-05-13","lastUpdate":"2013-05-21"},"enrollment":1001,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Open-Angle Glaucoma","Ocular Hypertension"],"interventions":[{"type":"DRUG","name":"Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension","otherNames":[]},{"type":"DRUG","name":"Brinzolamide ophthalmic suspension, 1%","otherNames":["AZOPTÂ®"]},{"type":"DRUG","name":"Brimonidine tartrate ophthalmic solution, 0.2%","otherNames":[]}],"arms":[{"label":"Brinzolamide/Brimonidine","type":"EXPERIMENTAL"},{"label":"Brinzolamide","type":"ACTIVE_COMPARATOR"},{"label":"Brimonidine","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study was to evaluate the efficacy and safety of a fixed combination of Brinzolamide/Brimonidine in lowering intraocular pressure (IOP) relative to each of its individual active components in patients with open-angle glaucoma and/or ocular hypertension.","primaryOutcome":{"measure":"Mean IOP at Month 3 for Each Assessment Timepoint (8 AM, + 2 h, + 7 h, and + 9 h)","timeFrame":"Month 3","effectByArm":[{"arm":"Brinzolamide/Brimonidine","deltaMin":20.5,"sd":0.29},{"arm":"Brinzolamide","deltaMin":21.6,"sd":0.28},{"arm":"Brimonidine","deltaMin":23.3,"sd":0.29}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":14},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["23579344"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":214},"commonTop":["Vision blurred","Dysgeusia"]}}